Barley and yeast β-glucans as new emulsifier agents for the development of aqueous natural antifungal formulations

被引:6
|
作者
Salgado M. [1 ]
Rodríguez-Rojo S. [1 ]
Cocero M.J. [1 ]
机构
[1] High Pressure Processes Group, Department of Chemical Engineering and Environmental Technology, EII Sede Mergelina, University of Valladolid, Valladolid
来源
Rodríguez-Rojo, Soraya (sorayarr@iq.uva.es) | 1600年 / Elsevier Ltd卷 / 174期
关键词
Botrytis cinerea; Encapsulation; High-pressure emulsification; Lecithin; Resveratrol; β-glucan;
D O I
10.1016/j.carbpol.2017.07.038
中图分类号
学科分类号
摘要
Barley and yeast β-glucans were selected, together with lecithin, to encapsulate resveratrol by emulsification-evaporation method to develop new and safer antifungal formulations. Different emulsification techniques were used: high-shear, high pressure and high pressure and temperature emulsification. Morphology, crystallinity, encapsulation efficiency and in vitro antifungal activity against Botrytis cinerea of the different formulations were evaluated. No significant differences between each emulsification procedure in particle size (below 90 nm) and in encapsulation efficiency (70–100%) were observed; only barley β-glucan emulsions showed lower efficiency due to the formation of a gel that retained most of the active compound. A great influence of the emulsification method and the encapsulating material on the crystallinity of the particles was observed. The highest antifungal activity (up to 53% growth inhibition) was obtained by the formulations with yeast β-glucans, indicating an enhanced absorption of encapsulated resveratrol through the cell wall of the fungus at the presence of (1–3, 1–6)-β-glucans. © 2017 Elsevier Ltd
引用
收藏
页码:1114 / 1120
页数:6
相关论文
共 27 条
  • [1] New Antifungal Agents and New Formulations Against Dermatophytes
    Gupta, Aditya K.
    Foley, Kelly A.
    Versteeg, Sarah G.
    MYCOPATHOLOGIA, 2017, 182 (1-2) : 127 - 141
  • [2] New Antifungal Agents and New Formulations Against Dermatophytes
    Aditya K. Gupta
    Kelly A. Foley
    Sarah G. Versteeg
    Mycopathologia, 2017, 182 : 127 - 141
  • [3] DEVELOPMENT OF NEW SYSTEMIC ANTIFUNGAL AGENTS
    WALKER, EM
    HYNES, JB
    GALE, GR
    WARMENHOVEN, LJ
    PILLINGER, C
    PREVOST, E
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 1980, 10 (05): : 453 - 454
  • [4] New antifungal agents under development in children and neonates
    Steinbach, WJ
    Benjamin, DK
    CURRENT OPINION IN INFECTIOUS DISEASES, 2005, 18 (06) : 484 - 489
  • [5] Antifungal Drugs: The Current Armamentarium and Development of New Agents
    Robbins, Nicole
    Wright, Gerard D.
    Cowen, Leah E.
    MICROBIOLOGY SPECTRUM, 2016, 4 (05):
  • [6] Role of New Antifungal Agents in the Treatment of Invasive Fungal Infections in Transplant Recipients: Isavuconazole and New Posaconazole Formulations
    Li, Julius
    Nguyen, Cynthia T.
    Garcia-Diaz, Julia
    JOURNAL OF FUNGI, 2015, 1 (03) : 345 - 366
  • [7] Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations
    Pitman, Stuart K.
    Drew, Richard H.
    Perfect, John R.
    EXPERT OPINION ON EMERGING DRUGS, 2011, 16 (03) : 559 - 586
  • [8] A new paradigm for the development of anticancer agents from natural products
    Subramanian, Balanehru
    Nakeff, Alexander
    Tenney, Karen
    Crews, Phillip
    Gunatilaka, Leslie
    Valeriote, Fred
    JOURNAL OF EXPERIMENTAL THERAPEUTICS AND ONCOLOGY, 2006, 5 (03) : 195 - 204
  • [9] In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agents
    Pfaller, MA
    Messer, SA
    Coffman, S
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (04) : 763 - 766
  • [10] The Significance of Mono- and Dual-Effective Agents in the Development of New Antifungal Strategies
    Zobi, Cengiz
    Algul, Oztekin
    CHEMICAL BIOLOGY & DRUG DESIGN, 2025, 105 (01)